Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Status:
Terminated
Trial end date:
2017-08-25
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of saxagliptin, an anti-diabetes
medication, on hepatic and myocardial fat content and monocyte inflammation in patients with
Impaired Glucose Tolerance (IGT).